ROTEF-D Tablets contain a combination of Drotaverine Hydrochloride 80 mg and Mefenamic Acid 250 mg in a film-coated tablet formulation. The product is supplied in 10×10 blister packing and is intended for use as directed by a qualified healthcare professional.
Key Highlights
- Drotaverine Hydrochloride 80 mg + Mefenamic Acid 250 mg
- Film-coated tablet formulation
- 10 × 10 blister packing
- Combination pharmaceutical formulation
- Prescription medicine
- Use as directed by a qualified healthcare professional






